Skip to main content
logo
HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
494.99
-12.49 (-2.46%)
At close: Nov 6, 2026, 4:00 PM EST
500.00
+5.01 (1.01%)
After-hours: Nov 6, 2026, 7:57 PM EST

HCA Healthcare Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Revenue
19,84920,23019,10919,51319,16118,60518,32118,28517,48717,49217,33917,30316,21315,86115,59115,49714,97114,82014,94515,064
Revenue Growth (YoY)
3.59%8.73%4.30%6.72%9.57%6.36%5.66%5.67%7.86%10.28%11.21%11.65%8.30%7.02%4.32%2.87%-2.00%2.67%6.93%5.39%
Cost of Revenue
11,40311,17611,13611,33711,14610,98210,76110,71010,51810,31910,37810,1549,9739,7559,5079,4849,2199,0939,2609,413
Gross Profit
8,4469,0547,9738,1768,0157,6237,5607,5756,9697,1736,9617,1496,2406,1066,0846,0135,7525,7275,6855,651
Selling, General & Admin
---1,030---1,049---994---976---989
Other Operating Expenses
4,5485,0434,1803,0574,1613,7933,8452,8243,7173,6233,6062,5663,3793,0432,8941,8742,8602,6932,7521,548
Operating Expenses
5,5025,9875,1104,9985,0504,6564,7054,7294,5594,4424,4014,3494,1483,8063,6503,6003,6093,4313,4843,265
Operating Income
2,9443,0672,8633,1782,9652,9672,8552,8462,4102,7312,5602,8002,0922,3002,4342,4132,1432,2962,2012,386
Interest Expense
-607-599-584-572-561-568-547-528-515-506-512-491-483-485-479-453-446-434-408-398
Earnings From Equity Investments
20169251619181015--22819-7-18161081135
EBT Excluding Unusual Items
2,3572,4842,2882,6312,4202,4182,3262,3281,9102,2252,0462,3371,6281,8081,9371,9761,7071,8701,8042,023
Gain (Loss) on Sale of Investments
-----------1--------
Gain (Loss) on Sale of Assets
1310-141-2-31-195-412201721-151,326-3-3210563
Other Unusual Items
------------------78--
Pretax Income
2,3702,4942,2872,6722,4182,4152,3272,1331,9062,2372,2472,3451,6301,8091,9223,3021,7041,7601,8142,586
Income Tax Expense
521564430509515524502447424550445484355397379656360381349581
Earnings From Continuing Operations
1,8491,9301,8572,1631,9031,8911,8251,6861,4821,6871,8021,8611,2751,4121,5432,6461,3441,3791,4652,005
Minority Interest in Earnings
-270-231-237-285-260-238-215-248-212-226-211-254-196-219-180-565-210-224-192-191
Net Income
1,5791,6991,6201,8781,6431,6531,6101,4381,2701,4611,5911,6071,0791,1931,3632,0811,1341,1551,2731,814
Net Income to Common
1,5791,6991,6201,8781,6431,6531,6101,4381,2701,4611,5911,6071,0791,1931,3632,0811,1341,1551,2731,814
Net Income Growth (YoY)
-3.90%2.78%0.62%30.60%29.37%13.14%1.19%-10.52%17.70%22.46%16.73%-22.78%-4.85%3.29%7.07%14.72%-50.02%-20.34%-10.54%27.21%
Shares Outstanding (Basic)
215221224231233239247255257261264271271274277286286293302315
Shares Outstanding (Diluted)
217223227231236242249255260264268271275278281286290296307315
Shares Change (YoY)
-8.03%-7.89%-9.14%-9.63%-9.13%-8.39%-6.93%-5.85%-5.63%-5.08%-4.61%-5.07%-4.98%-6.03%-8.59%-9.43%-10.55%-10.99%-10.47%-8.67%
EPS (Basic)
7.367.707.258.147.056.916.525.634.955.596.025.933.984.354.927.283.973.954.215.75
EPS (Diluted)
7.277.627.158.146.966.836.455.634.885.535.935.933.914.294.857.283.913.904.145.75
EPS Growth (YoY)
4.45%11.57%10.85%44.52%42.62%23.51%8.77%-4.95%24.81%28.90%22.27%-18.59%0%10.00%17.15%26.57%-44.14%-10.55%0%39.29%

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
3,1041,1048958703,1283,0346601,2742,3246901,3511,5151,3321,2346061,2041,8895504841,251
Free Cash Flow Per Share
14.294.953.953.7713.2412.542.654.998.942.615.045.594.844.442.164.216.521.861.573.97
Dividend Per Share
0.7800.7800.7800.7200.7200.7200.7200.6600.6600.6600.6600.6000.6000.6000.6000.5600.5600.5600.5600.480
Dividend Growth (YoY)
8.33%8.33%8.33%9.09%9.09%9.09%9.09%10.00%10.00%10.00%10.00%7.14%7.14%7.14%7.14%16.67%16.67%16.67%16.67%-
Gross Margin
42.55%44.76%41.72%41.90%41.83%40.97%41.26%41.43%39.85%41.01%40.15%41.32%38.49%38.50%39.02%38.80%38.42%38.64%38.04%37.51%
Operating Margin
14.83%15.16%14.98%16.29%15.47%15.95%15.58%15.57%13.78%15.61%14.76%16.18%12.90%14.50%15.61%15.57%14.31%15.49%14.73%15.84%
Profit Margin
7.95%8.40%8.48%9.62%8.58%8.88%8.79%7.86%7.26%8.35%9.18%9.29%6.65%7.52%8.74%13.43%7.58%7.79%8.52%12.04%
Free Cash Flow Margin
15.64%5.46%4.68%4.46%16.32%16.31%3.60%6.97%13.29%3.94%7.79%8.76%8.22%7.78%3.89%7.77%12.62%3.71%3.24%8.30%
EBITDA
3,8984,0113,7934,0893,8543,8303,7153,7023,2523,5503,3553,5892,8613,0633,1903,1632,8923,0342,9333,114
EBITDA Margin
19.64%19.83%19.85%20.95%20.11%20.59%20.28%20.25%18.60%20.29%19.35%20.74%17.65%19.31%20.46%20.41%19.32%20.47%19.63%20.67%
D&A For EBITDA
954944930911889863860856842819795789769763756750749738732728
EBIT
2,9443,0672,8633,1782,9652,9672,8552,8462,4102,7312,5602,8002,0922,3002,4342,4132,1432,2962,2012,386
EBIT Margin
14.83%15.16%14.98%16.29%15.47%15.95%15.58%15.57%13.78%15.61%14.76%16.18%12.90%14.50%15.61%15.57%14.31%15.49%14.73%15.84%
Effective Tax Rate
21.98%22.61%18.80%19.05%21.30%21.70%21.57%20.96%22.25%24.59%19.80%20.64%21.78%21.95%19.72%19.87%21.13%21.65%19.24%22.47%
SEC Filings: 10-K · 10-Q